GPT and anemia: The most common treatment-related hematological AEs were increased ALT/AST (n=13, 18.1%), anemia (n=11, 15.3%), decreased white blood count (n=6, 8.3%), hyperbilirubinemia (n=5,6.9%), and decreased platelet (n=4, 5.6%).